Safety and Efficacy of PRO 542 in the Treatment of HIV-Infected Patients

This study has been completed.
Sponsor:
Information provided by:
Progenics Pharmaceuticals, Inc.
ClinicalTrials.gov Identifier:
NCT00055185
First received: February 20, 2003
Last updated: October 2, 2008
Last verified: October 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2005
  Estimated Primary Completion Date: No date given